These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 15970262)
1. Peter Hug on the Roche philosophy to partnering. Interview by Stephen Carney. Hug P Drug Discov Today; 2005 Jun; 10(12):813-5. PubMed ID: 15970262 [No Abstract] [Full Text] [Related]
2. Partnering between pharma peers on the rise. Mullard A Nat Rev Drug Discov; 2011 Aug; 10(8):561-2. PubMed ID: 21804581 [No Abstract] [Full Text] [Related]
3. Academic medical centers and the pharmaceutical industry. Del Parigi A Clin Pharmacol Ther; 2010 Oct; 88(4):464-5. PubMed ID: 20703224 [No Abstract] [Full Text] [Related]
4. A reprise for collaborative financing in biotech. Ransom J Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110 [No Abstract] [Full Text] [Related]
5. Genomics companies shop around for chemical expertise. Fletcher L Nat Biotechnol; 2004 Feb; 22(2):137-8. PubMed ID: 14755277 [No Abstract] [Full Text] [Related]
6. The closure of Sugen. Levitzki A Nat Biotechnol; 2003 Sep; 21(9):969. PubMed ID: 12949548 [No Abstract] [Full Text] [Related]
7. Sugen falls as casualty of Pfizer-Pharmacia merger. Garber K Nat Biotechnol; 2003 Jul; 21(7):722-3. PubMed ID: 12833079 [No Abstract] [Full Text] [Related]
9. Advice for partnering with pharma. Howard K Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421 [No Abstract] [Full Text] [Related]
10. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
12. Outlook: finding improved medicines: the role of academic-industrial collaboration. Chin-Dusting J; Mizrahi J; Jennings G; Fitzgerald D Nat Rev Drug Discov; 2005 Nov; 4(11):891-7. PubMed ID: 16247439 [TBL] [Abstract][Full Text] [Related]
13. Alice Huxley and Nick Miles of Speedel on the company's pipeline and future plans. Interview by Christopher Watson and Stephen Carney. Huxley A; Miles N Drug Discov Today; 2005 Jul; 10(13):881-3. PubMed ID: 15993805 [No Abstract] [Full Text] [Related]
14. Roche and Igen in shotgun wedding. Bouchie A Nat Biotechnol; 2003 Sep; 21(9):958. PubMed ID: 12949542 [No Abstract] [Full Text] [Related]
15. [Marketing authorization for pharmaceuticals: the necessity of European collaboration]. Seitz R; Enzmann H Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):703-4. PubMed ID: 18592336 [No Abstract] [Full Text] [Related]
17. Bridging the Academia/Industry Chasm: Proposed Solutions. Beninger P; Boumil M; Salem D; Getz K; Klapholz H; Curfman GD; Jotwani R; Berman H J Clin Pharmacol; 2016 Dec; 56(12):1457-1460. PubMed ID: 27149908 [No Abstract] [Full Text] [Related]
18. Strategic groups in the biopharmaceutical industry: implications for performance. Erden Z; von Krogh G; Nytorp C; Hultberg M Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760 [TBL] [Abstract][Full Text] [Related]